What is the appropriate management for a serum iron level of 272 µg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Serum Iron Level of 272 µg/dL

A serum iron level of 272 µg/dL alone is insufficient to guide management—you must immediately measure transferrin saturation (TSAT) and serum ferritin to determine if iron overload exists and whether treatment is indicated.

Diagnostic Algorithm

The isolated serum iron value of 272 µg/dL requires contextualization through additional testing:

Step 1: Measure TSAT and Ferritin Immediately

According to the most recent EASL guidelines, provisional iron overload is diagnosed when BOTH of the following are present 1:

  • TSAT >50% in males and post-menopausal women (>45% in pre-menopausal women)
  • Ferritin >300 µg/L in males and post-menopausal women (>200 µg/L in pre-menopausal women)

Step 2: If Iron Overload is Confirmed

Order HFE genetic testing to identify C282Y homozygosity, which accounts for >95% of hereditary hemochromatosis cases 1.

Step 3: Assess for End-Organ Damage

Check the following to determine disease severity:

  • Liver enzymes (ALT, AST) to assess hepatic involvement
  • Liver elastography or imaging if ferritin >1000 µg/L to identify advanced fibrosis 2
  • Fasting glucose and HbA1c for diabetes screening
  • Joint examination for arthropathy
  • Cardiac assessment if symptomatic or in severe/early-onset cases 1

Treatment Decision Framework

If C282Y Homozygote with Confirmed Iron Overload:

Initiate therapeutic phlebotomy immediately 3:

  • Remove 500 mL blood weekly or biweekly as tolerated
  • Check hemoglobin/hematocrit before each phlebotomy
  • Do not allow hemoglobin to fall >20% from baseline
  • Monitor ferritin every 10-12 phlebotomies (approximately every 3 months)

Target ferritin levels 1, 3:

  • Induction phase: <50 µg/L
  • Maintenance phase: 50-100 µg/L

If Ferritin <1000 µg/L with Normal Liver Enzymes:

Proceed directly to phlebotomy without liver biopsy 3. The treatment is safe, inexpensive, and prevents progression to cirrhosis, diabetes, and hepatocellular carcinoma—complications that dramatically worsen morbidity and mortality 3.

If Advanced Disease is Present:

Exercise caution with phlebotomy frequency in patients with cardiac involvement, as rapid iron mobilization increases risk of sudden death from arrhythmias 3.

Critical Caveats

Avoid vitamin C supplementation during treatment—it accelerates iron mobilization beyond transferrin's capacity, creating toxic free radical activity 3.

No dietary iron restriction is necessary—dietary modification only affects 2-4 mg/day compared to 200-250 mg removed per phlebotomy 3.

If cirrhosis develops before treatment, continue lifelong HCC surveillance even after iron depletion, as HCC accounts for 30% of hemochromatosis-related deaths 3. However, HCC is exceptionally rare in non-cirrhotic patients, emphasizing the importance of early treatment 3.

If Iron Overload is NOT Confirmed

If TSAT and ferritin are normal despite the elevated serum iron of 272 µg/dL, this represents a transient elevation or laboratory variation—no treatment is indicated. Serum iron fluctuates significantly and is not a reliable standalone marker 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.